Meeting
2022 ASCO Genitourinary Cancers Symposium
68ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly).
Authors
Charlotte Manogue
Tulane University Cancer Center, New Orleans, LA
Charlotte Manogue , Grant Rauterkus , Malcolm Light , Isabelle P. Sussman , Alex Lieberman , Minqi Huang , Gaynelle Davis , Pedro C. Barata , Jodi Lyn Layton , Brian E. Lewis , Kendra Marie Harris , Hailey Manning , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Clinical Trial Registration Number
NCT04854369
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr TPS189)
DOI
10.1200/JCO.2022.40.6_suppl.TPS189
Abstract #
TPS189
Poster Bd #
P4
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
68Ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly Study): Preliminary results.
First Author: Charlotte Hawkins
Poster
2023 ASCO Annual Meeting
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
First Author: Alberto Carretero-González
Poster
2023 ASCO Genitourinary Cancers Symposium
Updated experience on PSMA PET/CT for recurrent prostate cancer in a high-volume Brazilian center.
First Author: Dr. Paulo Sergio Lages
Poster
2023 ASCO Genitourinary Cancers Symposium
Detection of true positive M1 lesions by 18F-rhPSMA-7.3 PET in newly diagnosed prostate cancer: Results from the phase 3 prospective LIGHTHOUSE study.
First Author: Bridget F. Koontz